Abstract
Serum hyperviscosity is a rare laboratory finding. Amongst several causes of serum hyperviscosity, malignant disorders are quite common. Monoclonal gammopathy is a family of disorders in which monoclonal gammopathy of unknown significance (MGUS) and smoldering myeloma are the asymptomatic variants whereas multiple myeloma is the malignant variant showing different signs and symptoms related to bone lesions, renal failure and anemia. Initially during sample preparation, pipetting of a serum sample was found to be cumbersome. This sample during routine analysis in the automated analyser flagged repeated alarms for clot detection indicating a possibility of a hyper viscous sample. Serum was subjected to fibrinogen and D- dimer test. The D-Dimer levels were found to be normal and fibrinogen levels were mildly elevated. Routine biochemistry investigations were normal except grossly reversed A/G ratio. Due to gross reversal of A/G ratio, the possibility of Multiple myeloma was entertained. Physician’s were alerted on telephone. Serum was sent for electrophoresis which showeda M spike. Bone marrow aspirate showed 13% plasma cells. Considering the above lab results the diagnosis of monoclonal gammopathy of smoldering type was considered. The sample was traced to a 77 years old male, who presented to Medicine OPD with the chief complaints of generalised weakness for two months without any history of fever. On physical examination pallor was evident but there was no icterus, cyanosis, clubbing, lymphadenopathy or edema. On haematological evaluation patient was found to be anemic. Careful tracking of hyperviscous patient’s serum followed up by thorough investigation led us to the final conclusion that the case mentioned is a rare case of Smoldering type of multiple myeloma.
Similar content being viewed by others
References
Encyclopedia, University of Rochester Medical Center Rochester, NY
Mullen E, Mendez N. Hyper viscosity in patients with multiple myeloma. OncNurs Forum. 2008;35:350–2.
Perez Rogers A, Estes M. Hyper viscosity Syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020
Han J, Wang J, Zhang Y. Prevalence of monoclonal gammopathy of undetermined significance in a large population with annual medical check-ups in China. Blood Cancer J. 2020;10:34.
Robert AK, Ellen DR, Terry MT. Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med. 2007;25:356.
Agarwal A, Ghobrial IM. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: a review of the current understanding of epidemiology, biology, risk stratification, and management of myeloma precursor disease. Clin Cancer Res. 2013;19(5):985–94.
Kaushansky K. Williams Hematology. United States: McGraw Hill; 2016. p. 1723–7.
Kyle RA, Remstein ED, Therneau TM. Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med. 2007;25(356):2582–90.
Blum A, Bazou D, O'Gorman P. Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions. Blood Lymphat Cancer. 2018;8:21–31. Published 2018 Apr 20
Rajkumar SV, Dimopoulos MA, Palumbo A. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538–48.
Joan B. Monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;355:26.
Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC. Multiple myeloma". Lancet.2009: 324–39
Rajkumar SV. Updated diagnostic criteria and staging system for multiple myeloma. Am SocClinOncolEduc Book. 2016;35:e418–23.
Rajkumar SV, Landgren O, Mateos MV. Smoldering multiple myeloma. Blood. 2015;125(20):3069–75.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares there is no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Birdi, A., Sinha, A., Banerjee, M. et al. Smouldering Myeloma: Chasing a Hyperviscous Sample. Ind J Clin Biochem 38, 279–283 (2023). https://doi.org/10.1007/s12291-021-00990-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-021-00990-1